Rima M. Saliba
Associate Professor
Department of Stem Cell Transplantation and Cellular Therapy
MD Anderson Cancer Center
United States of America
Biography
1997 University of Texas School of Public Health, Houston, TX, USA, PHD, Epidemiology/Biostatistics. 1986 American University of Beirut, Beirut, LBN, MS, Nutrition. 1983 American University of Beirut, Beirut, LBN, BS, Nutrition. Assistant Professor, Department of Stem Cell Transplantation - Research, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2005 - 2011.
Research Interest
Stem Cell Transplantation and Cellular Therapy
Publications
-
Popat U, de Lima MJ, Saliba RM, Anderlini P, Andersson BS, Alousi AM, Hosing C, Nieto Y, Parmar S, Khouri IF, Kebriaei P, Qazilbash M, Champlin RE, Giralt SA. Long-term outcome of reduced-intensity allogeneic hematopoietic SCT in patients with AML in CR. Bone Marrow Transplant 47 (2) :212-6, 2012
-
Saliba RM, Couriel DR, Giralt S, Rondon G, Okoroji GJ, Rashid A, Champlin RE, Alousi AM. Prognostic value of response after upfront therapy for acute GVHD. Bone Marrow Transplant 47 (1) :125-31, 2012
-
Paolo Anderlini, Rima Saliba, Sandra Acholonu, Grace-Julia Okoroji , Borje S. Andersson, Roy Jones, Uday R. Popat , Chitra M. Hosing, Yago Nieto, Muzaffar H. Qazilbash, Naoto T. Ueno, Sergio A. Giralt, Marcos J de Lima, Richard E. Champlin. Donor Leukocyte Infusions (DLIs) in recurrent Hodgkin Lymphoma (HL) following allogeneic stem cell transplantation: ten-year experience at the M.D. Anderson Cancer Center. Leukemia Lymphoma 53 (6) :1239-1241, 2013
